The Global Pharmaceutical Logistics Market Will Experience an Increase in Demand for Home Healthcare Products Through 2019
The Global Pharmaceutical Logistics Market is expected to grow at a CAGR of 9.71% from 2015–2019, according to a new report from research firm Technavio.
Many pharmaceutical logistics companies are now focusing on the expansion of their services and product portfolio to meet the global demand for home healthcare. Patients can easily use portable devices to check their blood pressure, glucose levels and other vital signs at home.
“The growth of the home healthcare segment has been a key factor in initiating several business and supply chain changes and is expected to drive growth in the pharmaceutical logistics sector over the next 10 years,” says Faisal Ghaus, Vice President of Technavio.
The Technavio report also highlights new methods of pharmaceutical delivery. Vendors are changing their transportation mode from air to sea for the delivery of medicines and drugs because of certain advantages, including a 70–80% reduction in cost.
Additionally, more vendors are relying on online services to deliver pharmaceutical products to patients. “Vendors have enhanced the use of online services like e-health records, remote monitoring, e-prescribing and mobile health applications, so as to ensure an effortless and quick delivery of medicines directly to patients,” says Ghaus.
Key Information Covered in the Report include:
• Market segmentation, size and forecast through 2019
• Market Growth Drivers:
• Increased Demand for Home Healthcare Products
• For a full detailed list, view the report.
• Market Challenges:
• Inefficient Product Labeling
• Market Trends:
• New Methods of Pharmaceuticals Delivery
• Key Vendors:
• DB Schenker
• Deutsche Post DHL
• FedEx
• United Parcel Service of America Inc.
• Other Prominent Vendors:
• Agility
• Biocair
• CEVA
• Cold Chain Technologies
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance